Early and late onset cardiotoxicity following anthracycline-based chemotherapy in breast cancer patients: Incidence and predictors.

José M Serrano, Rebeca Mata,Iria González,Silvia Del Castillo,Javier Muñiz,Luis J Morales, María Jesús Espinosa,Fernando Moreno,Rosa Jiménez,Carmen Cristobal,Catherine Graupner,Pedro Talavera,Carlos Gutierrez Landaluce,Alejandro Curcio,Javier Alonso,Juan A Guerra,Joaquín J Alonso

International journal of cardiology（2023）

引用 0|浏览7

暂无评分

摘要

Incidence of late-onset cardiotoxicity is high but mostly subclinical. Diastolic dysfunction early after chemotherapy is a strong predictor of anthracycline cardiotoxicity.

查看译文

关键词

Anthracycline chemotherapy,Breast cancer,Cardiac biomarkers,Diastolic dysfunction

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要